ROR2 blockade as a therapy for osteoarthritis.

Area of Science:

• Biochemistry
• Cell Biology
• Orthopedics

Background:

• Osteoarthritis (OA) involves articular cartilage loss, bone remodeling, pain, and disability.
• Current pharmacological treatments cannot halt OA progression.
• Receptor tyrosine kinase-like orphan receptor 2 (ROR2) is implicated in OA pathogenesis.

Purpose of the Study:

• To investigate the role of ROR2 in osteoarthritis.
• To evaluate the therapeutic potential of blocking ROR2 signaling in OA models.
• To elucidate the downstream signaling pathways affected by ROR2 in OA.

Main Methods:

• Studied ROR2 expression in response to inflammatory cytokines and mechanical stress.
• Utilized in vitro cell culture models (C3H10T1/2 cells, human articular chondrocytes).
• Employed mouse models of instability-induced osteoarthritis and evaluated ROR2 silencing effects.

Main Results:

• ROR2 was upregulated in OA cartilage; its ligand WNT5A and downstream targets YAP and CTGF were also elevated in human OA.
• ROR2 blockade promoted chondrogenic differentiation and suppressed cartilage-degrading enzymes (ADAMTS-4, ADAMTS-5) in vitro.
• ROR2 silencing in mice improved structural outcomes, reduced pain, and showed no toxicity; human chondrocyte studies indicated conserved anabolic effects.

Conclusions:

• Blocking ROR2 inhibits YAP signaling, improving cartilage integrity and pain in OA models.
• ROR2 blockade demonstrates efficacy and tolerability in preclinical OA models.
• ROR2 inhibition represents a promising therapeutic strategy for osteoarthritis with potential human applications.